William B. Armiger, Ph.D., President of BioChemInsights, has over 30 years of technical and business experience in chemicals, pharmaceuticals and biotechnology.Dr. Armiger began his career by founding BioChem Technology as a high-tech R&D company developing, licensing, and commercializing products and technology for use in bioprocessing.
His career has included senior positions with Arthur D. Little, VP of Biotechnology for The Catalyst Group, Vice President Fine Chemicals with Venture Catalysts, and more recently, Vice President, Specialty Chemicals for Lignol Innovations and President, NeuroGenomeX. Dr. Armiger has led numerous business and technical projects relating to the development and commercial production of fine chemical and pharmaceutical products by chemical synthesis, fermentation, cell culture, and enzymatic processes.He has worked closely with clients identifying strategic partners and structuring relationships for technology innovation and product marketing within the chemical and pharmaceutical sectors. He has provided strategic business development services in pharmaceutical fine chemicals and biotechnology and has been involved in successful merger and acquisition assignments with specialty chemical companies for microbial and biocatalyst technology used for manufacturing high-value pharmaceutical intermediates.Other recent activities have involved the development of growth strategies by acquisition of targeted pharmaceutical fine chemical companies.
Dr. Armiger received his B.S.E. in Chemical Engineering from PrincetonUniversity and his Ph.D. in Chemical and Biochemical Engineering from the University of Pennsylvania. He is a Registered Engineer in the Commonwealth of Pennsylvania.
